Antineoplastic treatment effect on bone mineral density in Mexican breast cancer patients

• Published in: BMC cancer Vol. 16; no. 1; p. 860
• Main Authors: Monroy-Cisneros, Karina, Esparza-Romero, Julián, Valencia, Mauro E, Guevara-Torres, Alfonso G, Méndez-Estrada, Rosa O, Anduro-Corona, Iván, Astiazarán-García, Humberto
• Format: Journal Article
• Language: English
• Published: England BioMed Central Ltd 08.11.2016; BioMed Central
• Subjects: Adult; Alfacalcidol; Antineoplastic Agents - adverse effects; Antineoplastic Agents - therapeutic use; Antineoplastic Combined Chemotherapy Protocols - adverse effects; Antineoplastic Combined Chemotherapy Protocols - therapeutic use; Biomarkers, Tumor; Bone Density; Bone Diseases - etiology; Bone Diseases - pathology; Bone resorption; Breast cancer; Breast Neoplasms - complications; Breast Neoplasms - diagnosis; Breast Neoplasms - drug therapy; Breast Neoplasms - metabolism; Calcifediol; Cancer; Care and treatment; Chemotherapy; Diagnosis; Dosage and administration; Female; Health aspects; Humans; Menopause; Mexico; Middle Aged; Neoplasm Staging; Postmenopausal women; Risk Factors; Vitamin D; Bone resorption; Chemotherapy; Calcium; Menopause; Breast neoplasm

Breast cancer is the most deadly malignancy in Mexican women. Although treatment has improved, it may significantly affect bone mineral status in those who receive it. The aim of this study was to assess the impact of cancer treatment on bone mineral density (BMD) and bone mineral content (BMC), in...